Jefferson scientists create first transgenic mouse model of hepatitis B-based liver disease

The work holds promise for understanding the mechanisms of disease and for drug discovery

Researchers at Jefferson Medical College have developed the first mouse model of chronic liver disease caused by hepatitis B virus (HBV), which promises to accelerate the discovery of drugs against the disease. Such a model may provide a better understanding of how HBV actually causes liver disease.

Mark A. Feitelson, Ph.D., professor of pathology, anatomy and cell biology at Thomas Jefferson University in Philadelphia and his colleagues there developed transgenic mice that are chronic carriers of HBV. These mice were made by introducing the HBV genetic information into mouse eggs, and breeding mice that had viral DNA in all of their cells. Such mice consistently replicate HBV, which is detected in their blood, throughout their lives. Although other similar models have been made using normal mice, none develop chronic liver disease because the immune system sees the virus as -- self -- during embryonic development.

To solve this problem, Dr. Feitelson used severe combined immunodeficient (SCID) mice as viral hosts. These SCID mice lack critical immune system elements that normally would fight the virus. When the mice are reconstituted with a normal immune system in a procedure akin to bone marrow transplantation, they do not recognize the virus as -- self-- and develop liver disease.

The researchers report their results in August in the journal Nature Medicine.

"The mice see the virus as foreign, which is what they should do," Dr. Feitelson explains. This is similar to the way the human immune system recognizes HBV shortly after exposure to the virus, he points out.

In addition to chronic liver disease, these mice have also been manipulated to develop acute disease. "The differences between acute and chronic disease in these mice will be key to th

Contact: Steve Benowitz
Thomas Jefferson University

Page: 1 2 3

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:

(Date:8/2/2018)... ... August 02, 2018 , ... RxS ... and biotech companies, today announced that Mark Jara, principal of the organization, has ... the life sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... PA’s, RN’s, LPN’s, MA's and Administrative staff. , This full day course is ... biologics. The course will expose your staff to regenerative medicine procedures and processing ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... welcomes William “Will” Muzek as Business Development Manager. In this role, Mr. Muzek ... and to accelerate Lifecycle’s continued growth and expansion. , With over 20 ...
Breaking Biology News(10 mins):
(Date:7/31/2018)... ... 2018 , ... Leading regenerative veterinary medicine company, VetStem Biopharma, ... adipose tissue-derived stem cells to treat or prevent inflammation at the site of ... specifically, VetStem has been issued similar patents that cover the United States as ...
(Date:7/26/2018)... ... July 26, 2018 , ... Ariadne ... of a biofield energy treated nutraceutical to improve anti-inflammatory and immune function responses. ... assessed in the preclinical research, were significantly reduced. Results are as follows:, ...
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... 2018 , ... R3 Stem Cell is now offering regenerative therapies for COPD ... Double Board Certified providers, with outcomes significantly improving patient quality of life. , Traditional ... nothing to help repair and regenerate damaged lung tissues. Stem cell therapy for ...
Breaking Biology Technology:
Cached News: